67618-13-7Relevant academic research and scientific papers
METHODS OF INHIBITING PRO MATRIX METALLOPROTEINASE ACTIVATION
-
, (2012/12/13)
This invention relates to methods for preventing, treating or ameliorating an MMP9 and/or MMP13 mediated syndrome, disorder or disease comprising administering to a subject in need thereof an effective amount of a compound listed in the examples section of this specification, or a form, composition or medicament thereof. Disorders treated and/or prevented include rheumatoid arthritis.
4′-Methyl-4,5′-bithiazole-based correctors of defective ΔF508-CFTR cellular processing
Yoo, Choong Leol,Yu, Gui Jun,Yang, Baoxue,Robins, Lori I.,Verkman,Kurth, Mark J.
, p. 2610 - 2614 (2008/12/21)
The synthesis and ΔF508-CFTR corrector activity of a 148-member methylbithiazole-based library are reported. Synthetic routes were devised and optimized to generate methylbithiazole analogs in four steps. Corrector potency and efficacy were assayed using epithelial cells expressing human ΔF508-CFTR. These structure-activity data establish that the bithiazole substructure plays a critical function; eight novel methylbithiazole correctors were identified with low micromolar potencies.
